Drug-induced hepatitis: Diagnosis and management;Hepatites medicamenteuses: Diagnostic et prise en charge

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 8-9, 1999, Pages 906-914

  Mallat, Ariane ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALLOPURINOL; ANTIANDROGEN; CARBAMAZEPINE; CIBENZOLINE; CIPROFIBRATE; CLARITHROMYCIN; CLOZAPINE; COUMARIN ANTICOAGULANT; DEXCHLORPHENIRAMINE; ETODOLAC; FENOFIBRATE; FLUCONAZOLE; FLUOXETINE; HALOTHANE; IPRONIAZID; ISONIAZID; KETOCONAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOSIDE ANALOG; PARACETAMOL; PROTEINASE INHIBITOR; PYRAZINAMIDE; SULFANILAMIDE; TACRINE; TIANEPTINE; TISOPURINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

ALGORITHM; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; REVIEW; RISK FACTOR; TOXIC HEPATITIS; TREATMENT INDICATION; ACUTE DISEASE;

ACUTE DISEASE; HEPATITIS, TOXIC; HUMANS;

EID: 0032833807     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. e mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables. Gastroenterol Clin Biol 1998;22:1004-44.
2. Larrey D. Hépatites aiguës médicamenteuses. Imputabilité et aspects cliniques. Gastroenterol Clin Biol 1995; 19:B57-62.
3. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen : hepatoxicity after multiple doses in children. J Pediatr 1998;132:22-7.
4. Marotta PJ, Roberts EA. Pemoline hepatotoxicity in children. J Pediatr 1998;132:894-7.
5. Assal F, Spahr L, Hadengue A, Rubbia-Brandt L, Burkhard PR, Rubbici-Brandt L. Tolcapone and fulminant hepatitis. Lancet 1998;352:958.
6. Barki J, Larrey D, Pageaux G, Lamblin G, Gineston JL, Michel H. Hépatite subfulminante d'évolution fatale au cours d'un traitement par l'alpidem (Ananxyl). Gastroenterol Clin Biol 1993;17:872-4.
7. Caroli-Bosc FX, Chichmanian RM, Caumes E, Saint-Paul MC, Marty P, Demarquay JF, et al. Hépatite aiguë induite par l'association de tiliquinol et de tilbroquinol (Intetrix). Gastroenterol Clin Biol 1996;20:605-6.
8. Neuschwander-Tetri BA, Isley WL, Oki JC, Ramrakhiani S, Quiason SG, Phillips NJ, et al. Troglitazone-induced hepatic failure leading to liver transplantation. A case report. Ann Intern Med 1998; 129:38-41.
9. McCormick PA, Kennedy F, Curry M, Traynor O. COX 2 inhibitor and fulminant hepatic failure. Lancet 1999; 353:40-1.
10. van der Klauw MM, Houtman PM, Stricker BH, Spoelstra P. Hepatic injury caused by benzbromarone. J Hepatol 1994;20:376-9.
11. Danan G. Définitions et critères d'imputation des atteintes hépatiques aigues médicamenteuses. Conclusions d'une réunion internationale de consensus. Gastroenterol Clin Biol 1993;17 :H18-21.
12. Andreu V, Mas A, Bruguera M, Salmeron JM, Moreno V, Nogue S, et al. Ecstasy : a common cause of severe acute hepatotoxicity. J Hepatol 1998;29:394-7.
13. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997;26:47-51.
14. Mallat A, Dhumeaux D. Cocaine and the liver. J Hepatol 1991;12:275-8.
15. Babany G, Pessayre D, Benhamou JP. Hépatite au diclofénac. Gastroenterol Clin Biol 1983;7:316.
16. Charton-Bain MC, Flamant M, Aubertin JM, Belair MF, Gilquin J, Kazatchkine M, et al. Acidose lactique et altérations mitochondriales hépatiques au cours d'un traitement par zidovudine. Gastroenterol Clin Biol 1997;21:979-81.
17. Paterson D, Kerlin P, Walker N, Lynch S, Strong R. Piroxicam induced submassive necrosis of the liver. Gut 1992;33:1436-8.
18. Van Steenbergen W, Peeters P, De Bondt J, Staessen D, Buscher H, Laporta T, et al. Nimesulide-induced acute hepatitis : evidence from six cases. J Hepatol 1998;29: 135-41.
19. Andrade RJ, Lucena M, Vega JL, Torres M, Salmeron FJ, Bellot V, et al. Acarbose-associated hepatotoxicity. Diabetes Care 1998;21:2029-30.
20. Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel H, et al. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut 1992;33:368-71.
21. Stricker BHC. Drug-induced hepatic injury. 2nd ed. Amsterdam : Elsevier, 1992.
22. Beaune PH, Lecœur S. Immunotoxicology of the liver : adverse reactions to drugs. J Hepatol 1997;26 Suppl 2:37-42.
23. Remy AJ, Larrey D, Pageaux GP, Ribstein J, Ramos J, Michel H. Cross hepatotoxicity between tricyclic anti-depressants and phenothiazines. Eur J Gastroenterol Hepatol 1995;7:373-6.
24. Funck-Brentano C, Pessayre D, Benhamou JP. Hépatites dues àdivers derives de l'érythromycine. Gastroentero J Clin Biol 1983;7:362-9.
25. Hasan F. Isoflurane hepatotoxicity in a patient with a previous history of halothane-induced hepatitis. Hepatogastroenterology 1998;45:518-22.
26. Elliott RH, Strunin L. Hepatotoxicity of volatile anaesthetics. Br J Anaesth 1993;70:339-48.
27. Durand F, Bernuau J, Pessayre D. Hépatotoxicité des médicaments antituberculeux : implications pratiques pour la surveillance. Gastroenterol Clin Biol 1998;22: 117-20.
28. Dhumeaux D, Mallat A. Hépatites chroniques et cirrhoses d'origine médicamenteuse. Gastroenterol Clin Biol 1993;17:H31-5.
29. Ganne-Carrie N, de Leusse A, Guettier C, Castera L, Levecq H, Bertrand HJ, et al. Hépatites d'allure auto-immune induites par les fibrates. Gastroenterol Clin Biol 1998;22:525-9.
30. Larrey D, Michel H. Pathologie biliaire due aux médicaments. Gastroenterol Clin Biol 1993;17 : H59-65.
31. Skandrani K, Richardet JP, Duvoux C, Cherqui D, Zafrani ES, Dhumeaux D. Transplantation hépatique pour ductopénie sévère associée à la prise de thiabendazole. Gastroenterol Clin Biol 1997;21:623-5.
32. Chalasani N, Wilcox CM. Etiology, evaluation, and outcome of jaundice in patients with acquired immunodeficiency syndrome. Hepatology 1996;23:728-33.
33. Lenzo NP, Garas BA, French MA. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient : a case report [letter]. Aids 1997;11: 1294-6.
34. Berson A, Fromenty B, Letteron P, Pessayre D. Rôle des mitochondries dans l'hépatotoxicité des médicaments. Gastroenterol Clin Biol 1998;22:59-72.
35. Brau N, Leaf HL, Wieczorek RL, Margolis DM. Severe hepatitis in three AIDS patients treated with indinavir [letter ; comment]. Lancet 1997;349:924-5.
36. Picard O, Rosmorduc O, Cabane J. Hepatotoxicity associated with ritonavir. Ann Intern Med 1998;129:670-1.
37. John M, Flexman J, French MA. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors : an immune restoration disease ? Aids 1998;12:2289-93.
38. Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol : analysis of instances of therapeutic misadventure. Hepatology 1995;22:767-73.
39. Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995;346:547-52.